IBRX ImmunityBio, Inc. logo

IBRX ImmunityBio, Inc.

Healthcare
$7.92+9.70%ClosedMarket Cap: $8.30B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

283

13F Shares

168,995,792

Ownership %

17.9%

New Positions

44

Increased Positions

142

Closed Positions

30

Reduced Positions

64

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBPVirtus Biotech ETF357,7474.68%
CNCRLoncar Cancer Immunotherapy ETF104,7363.28%
GERMETFMG Treatments, Testing and Advancements ETF64,6713.14%
RVERTrenchless Fund ETF609,0673.13%
IDNAiShares Genomics Immunology and Healthcare ETF533,8622.46%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF139,4942.09%
CBSEClough Select Equity ETF93,1201.70%
VALT123,0841.40%
XBI10,244,0250.99%
LABUDirexion Daily S&P Biotech Bull 3X ETF513,1570.76%
IBBQInvesco Nasdaq Biotechnology ETF60,4620.58%
BIBProShares - Ultra Nasdaq Biotechnology45,9910.46%
IBBiShares Biotechnology ETF2,572,7010.22%
VTWG223,0320.15%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF130,2220.15%
GINNGoldman Sachs Innovate Equity ETF42,9600.15%
BKSEBNY Mellon US Small Cap Core Equity ETF11,9490.12%
RFLRInnovator U.S. Small Cap Managed Floor ETF10,6310.12%
STXKStrive Small-Cap ETF11,4770.12%
NLO1,989,2170.11%